Biodesix (BDSX) Return on Equity (2020 - 2026)

Biodesix (BDSX) has reported Return on Equity for 7 consecutive years, with 0.1% the latest figure, recorded in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.1%, down 7.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.1% (down 7.0% YoY), and the FY2025 annual result was 0.04%, down 1.0% from the prior year.
• Return on Equity was 0.1% for Q1 2026 at Biodesix, down from 0.17% in the prior quarter.
• Over five years, Return on Equity peaked at 1.37% in Q3 2025 and troughed at 0.32% in Q4 2023.
• Average Return on Equity over 5 years is 0.13%, with a median of 0.03% recorded in 2024.
• The widest YoY moves for Return on Equity: up 138 bps in 2025, down 102 bps in 2025.
• Over 5 years, Return on Equity stood at 0.07% in 2022, then sank by 390 bps to 0.32% in 2023, then soared by 95 bps to 0.02% in 2024, then jumped by 1069 bps to 0.17% in 2025, then slumped by 158 bps to 0.1% in 2026.
• Per Business Quant data, the three most recent Return on Equity figures were 0.1% in Q1 2026, 0.17% in Q4 2025, and 1.37% in Q3 2025.